| CASE REPORT |
|
| Year : 2019 | Volume
: 18
| Issue : 2 | Page : 189-191 |
|
|
Jaffe–Campanacci syndrome: Any role for99mTc-methylene diphosphonate bone and99mTc-octreotide scans for evaluation of the disorder?
Mohsen Qutbi, Sajad Ghanbari, Isa Neshandar Asli, Babak Shafiei
Department of Nuclear Medicine, Taleghani Educational Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Correspondence Address:
Mohsen Qutbi
Department of Nuclear Medicine, Taleghani Hospital, Yaman St., Velenjak, Tehran 1985711151
Iran
  | Check |
DOI: 10.4103/wjnm.WJNM_21_18 PMID: 31040754 
|
|
|
Jaffe–Campanacci syndrome (JCS) is a rare clinical disorder with almost unknown etiology. The main feature of this syndrome is skeletal involvement as nonossifying fibroma which may cause severe morbidity to these patients. X-ray imaging is the widely available modality for evaluation of skeleton, but radionuclide imaging modalities may have a role in workup. Herein, we present a case of JCS evaluated with99mTc-methylene diphosphonate bone and99mTc-octreotide scans for the extent of skeletal involvement. To the best of our knowledge, from over than 30 cases reported in the literature, no evaluation with radionuclide imaging has been done.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Users Online: 57 
